Prospective comparative study of 18F-sodium fluoride PET/CT and planar bone scintigraphy for treatment response assessment of bone metastases in patients with prostate cancer.

CONCLUSION: There was no difference between NaF PET/CT and BS in the detection of PD and non-PD; however, BS seemingly detects PD by the PCWG-2 criteria earlier than NaF-PET, which might be explained by the fact that NaF-PET is more sensitive at the baseline scan. PMID: 29447047 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29447047?dopt=Abstract

Source: Acta Oncologica - February 15, 2018 Category: Cancer & Oncology Authors: Fonager RF, Zacho HD, Langkilde NC, Fledelius J, Ejlersen JA, Hendel HW, Haarmark C, Moe M, Mortensen JC, Jochumsen MR, Petersen LJ Tags: Acta Oncol Source Type: research